Scpharmaceuticals Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SCPHARMACEUTICALS
SCPHARMACEUTICALS has one approved drug.
There are four US patents protecting SCPHARMACEUTICALS drugs.
There are twenty-three patent family members on SCPHARMACEUTICALS drugs in fifteen countries.
Summary for Scpharmaceuticals
| International Patents: | 23 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Scpharmaceuticals
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scpharmaceuticals | FUROSCIX | furosemide | SOLUTION;SUBCUTANEOUS | 209988-001 | Oct 7, 2022 | RX | Yes | Yes | 10,272,064 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Scpharmaceuticals | FUROSCIX | furosemide | SOLUTION;SUBCUTANEOUS | 209988-001 | Oct 7, 2022 | RX | Yes | Yes | 9,884,039 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Scpharmaceuticals | FUROSCIX | furosemide | SOLUTION;SUBCUTANEOUS | 209988-001 | Oct 7, 2022 | RX | Yes | Yes | 12,370,168 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Scpharmaceuticals Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2823589 | ⤷ Start Trial |
| Singapore | 10201709388Q | ⤷ Start Trial |
| Japan | 2019001821 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
